Walmart Q1 Earnings Likely Boosted By Inflation
Our preview of the upcoming week's earnings reports includes Walmart (WMT), Lowe's (LOW) and Kohl's (KSS).
The latest consumer price index (CPI) released last week indicates inflation remained sky-high in April. And while rising prices were a headwind for most companies in the first three months of 2022, they likely served as a tailwind for mega-retailer Walmart (WMT, $147.48).
Wall Street will find out this week, with WMT an early entrant on the earnings calendar; WMT will report its first-quarter results ahead of the May 17 open.
The consumer staples stock has shown resilience amid the recent market volatility, up roughly 2% for the year-to-date compared to a more than 17% decline for the broader S&P 500.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
WMT beat on both the top and bottom lines in its fourth quarter thanks in part to its ability to keep prices competitive in a high-inflation environment. And this trend probably continued in Q1, despite a challenging backdrop, says UBS Global Research analyst Michael Lasser (Buy).
"With low prices as its core value proposition, WMT is uniquely positioned to benefit from rising inflation," the analyst adds. "Its scale helps give it the ability to keep healthy price gaps versus its peers, which can help it achieve further share gains in the grocery channel.
While Lasser admits there will likely be some "moving pieces" in the report – including unpredictability related to macro headwinds – components such as U.S. same-store sales and full-year guidance will be good.
"We view WMT's shares as compelling as they offer more certainty than others in this uncertain backdrop," the analyst says.
Amid tough year-over-year (YoY) comparisons that include last year's stimulus-related pop, consensus estimates are for Walmart to report a 12.4% drop in earnings to $1.48 per share. Revenue is expected to arrive at $138.8 billion (+0.4% YoY).
Lowe's Faces Tough Comps in Q1
First-quarter earnings from Lowe's (LOW, $191.70) are due out before Wednesday's open. Similar to Walmart, the home improvement retailer is facing hard comparisons from Q1 2021.
As such, analysts, on average, are calling for a slim 0.9% YoY rise in earnings to $3.24 per share. And revenue is projected to be flat at $23.8 billion.
Still, Lowe's entered 2022 with momentum following a solid fourth-quarter print, says UBS Global Research analyst Michael Lasser (Buy).
Additionally, the consumer discretionary name raised its full-year guidance in February. This reflects an inflation tailwind due to LOW's "prudent pricing power" that will likely last for at least a few more quarters, the analyst adds.
"We believe LOW is building a track record of solid execution with every passing quarter," Lasser says. "Plus, it has several unique drivers to propel its results in the next few years independent of the market growth."
Kohl's Top and Bottom Lines Probably Contracted in Q1
Kohl's (KSS, $47.51) will report its first-quarter earnings ahead of the May 19 open.
The department store chain ended 2021 with record adjusted earnings of $7.33 per share and year-over-year revenue growth of 21.8% to $19.4 billion.
And Deutsche Bank analyst Gabriella Carbone (Buy) thinks the company is just getting started. "KSS has laid the groundwork for growth along with improving profitability, and is a more nimble company today than it was pre-pandemic," Carbone says.
Included in the company's plans to drive growth are goals for Kohl's to reach $2 billion in sales from its partnership with beauty company Sephora and expand its operating margin to a range of 7% to 8%.
Carbone adds that these goals "may prove to be prudent as management has greatly considered a number of headwinds," including supply-chain woes and a tight labor market.
As for the retail stock's first-quarter results, analysts, on average, expect earnings to arrive at 72 cents per share (-31.4% YoY) and revenue to land at $3.7 billion (-0.5% YoY).
In addition to the company's financial results, Wall Street will be looking for additional updates on the company's strategic initiatives. Last Wednesday, shareholders voted on Kohl's new slate of directors, rejecting an attempt from Macellum Advisors to add its nominees to the board. The activist investor has been pushing KSS to make changes, including unloading some of its real estate and putting itself up for sale.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Will President Trump's Medicare Executive Order Raise Drug Prices?
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.
By Donna Fuscaldo Last updated
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Stocks Jump Ahead of Trump Inauguration
The Dow and S&P 500 scored their biggest weekly gains since the early November election.
By Karee Venema Published
-
Stock Market Today: Stocks Pause After a Big Rally
The Nasdaq continues to lag the S&P 500 and the Dow so far in 2025.
By David Dittman Published
-
Stock Market Today: Dow Pops 703 Points on Cooler Inflation
A benign reading from the Consumer Price Index report assuaged market fears about the path of borrowing costs.
By Dan Burrows Published
-
Stock Market Today: Stocks Are Mixed Ahead of CPI
Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.
By David Dittman Published
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Dow Slides 697 Points on Super-Hot Jobs Data
When the December nonfarm payrolls report hit the tape, there was no question which way stocks would go at Friday's opening bell.
By David Dittman Published
-
Blowout December Jobs Report Puts Rate Cuts on Ice: What the Experts Are Saying
Jobs Report The strongest surge in hiring since March keeps the Fed on hold for now.
By Dan Burrows Published